We are live on ! Find out more

IBX

Tradr 2X Long IBM Daily ETF

IBX

Market cap $71.7M

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial

MELBOURNE, Australia--(BUSINESS WIRE)---- $IBX #FDA--IBX announced that it has secured firm commitments for AU$3.75M (US$2.59M) in new capital following the FDA's clearance of IND for a Phase 2 trial.

Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial

Imagion Biosystems' IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review

MELBOURNE, Australia--(BUSINESS WIRE)---- $IBX #FDA--Imagion's IND Application for HER2 MagSense® Imaging Agent Phase 2 Clinical Trial Has Cleared FDA Review. Company to proceed with clinical trial.

Imagion Biosystems' IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review

See News Rankings